SIA
ABUS icon

Sit Investment Associates’s Arbutus Biopharma ABUS Stock Holding History

Sit Investment Associates’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-71,200
Closed -$434K – 475
2015
Q3 		$434K Hold
71,200
– – 0.01% 375
2015
Q2 		$844K Hold
71,200
– – 0.02% 328
2015
Q1 		$1.24M Sell
71,200
-23,850
-25% -$489K 0.02% 284
2014
Q4 		$1.44M Buy
+95,050
New +$1.64M 0.02% 297

Other funds holding ABUS

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Axa
Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Sit Investment Associates's ABUS Position: Q4 2015 in Review

Sit Investment Associates sold out of Arbutus Biopharma (ABUS) in Q4 2015, closing a stake of 71,200 shares — an estimated $434K sold.

Sit Investment Associates first reported a position in ABUS in Q4 2014 and held it in 4 quarters. The position peaked at $1.44M in Q4 2014. 51 funds tracked by Wall St. Rank hold ABUS as of Q4 2015.

  • Sit Investment Associates reported no remaining Arbutus Biopharma position as of Q4 2015 after selling out during the quarter.
  • Sit Investment Associates sold 71,200 Arbutus Biopharma shares in Q4 2015, an estimated $434K.
  • Sit Investment Associates first reported a position in Arbutus Biopharma in Q4 2014 and held it in 4 quarters.
  • Sit Investment Associates's Arbutus Biopharma position peaked at $1.44M in Q4 2014.
  • 51 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q4 2015.

Based on Sit Investment Associates's 13F filing for Q4 2015, filed 20 Jan 2016.